..what small cap Biotech has 3 drugs in, or soon to be in,
Phase 3 trials that are 3 months in duration? And all of which have a proven safety profile. AMPE just needs 1 of these drugs to make it to approval for it to be appreciably higher. Gross manipulation by the shorts here.